BBLG News and Press, Bone Biologics Corp From 12/28/23

2023-12-28 10:00:05 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming Healthcare and utilities could perform better in 2024 - analyst Arcus, Bristol-Myers, and R1 RCM are Citi’s top stocks in healthcare For further details see:...

2023-12-27 12:58:17 ET Gainers: RiskOn International ( ROI ) +175% . Cytokinetics ( CYTK ) +77% . Cingulate ( CING ) +77% . First Wave BioPharma ( FWBI ) +71% . Vince Holding Corp ( VNCE ) +40% . Bakkt Holdings ( BKKT ) ...

2023-12-18 13:44:30 ET More on Bone Biologics Seeking Alpha’s Quant Rating on Bone Biologics Historical earnings data for Bone Biologics Financial information for Bone Biologics For further details see: Bone Biologics to conduct 1-for-8 reverse sto...

Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-8. The reverse st...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,139,063 of its shares of common stock at a ...

2023-11-17 09:39:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Li Auto (NASDAQ: LI ) stock fans will want to mark their calendars for Dec. 4 as a major catalyst for the electric vehicle (EV) company’s shares will take place on that d...

2023-11-17 09:01:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ChargePoint (NYSE: CHPT ) stock is sliding lower on Friday after the electric vehicle (EV) charging company released preliminary earnings data for the third quarter . The ba...

2023-11-17 08:37:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bone Biologics (NASDAQ: BBLG ) stock is falling on Friday after the medical device company’s shares underwent a major rally the day prior. That rally was caused by he...

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,139,063 of its shares of common stock at a purchase price of $0.64 per share in...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...